164 related articles for article (PubMed ID: 8369351)
21. Heat-sterilized PD fluid blocks leukocyte adhesion and increases flow velocity in rat peritoneal venules.
Jonasson P; Bagge U; Wieslander A; Braide M
Perit Dial Int; 1996; 16 Suppl 1():S137-40. PubMed ID: 8728180
[TBL] [Abstract][Full Text] [Related]
22. 3,4-Dideoxyglucosone-3-ene (3,4-DGE): a cytotoxic glucose degradation product in fluids for peritoneal dialysis.
Linden T; Cohen A; Deppisch R; Kjellstrand P; Wieslander A
Kidney Int; 2002 Aug; 62(2):697-703. PubMed ID: 12110035
[TBL] [Abstract][Full Text] [Related]
23. Toxicity of heat sterilized peritoneal dialysis fluids is derived from degradation of glucose.
Martinson E; Wieslander A; Kjellstrand P; Boberg U
ASAIO J; 1992; 38(3):M370-2. PubMed ID: 1457884
[TBL] [Abstract][Full Text] [Related]
24. Necrosis and apoptosis of polymorphonuclear cells exposed to peritoneal dialysis fluids in vitro.
Cendoroglo M; Sundaram S; Groves C; Ucci AA; Jaber BL; Pereira BJ
Kidney Int; 1997 Dec; 52(6):1626-34. PubMed ID: 9407510
[TBL] [Abstract][Full Text] [Related]
25. Biological significance of reducing glucose degradation products in peritoneal dialysis fluids.
Wieslander A; Linden T; Musi B; Carlsson O; Deppisch R
Perit Dial Int; 2000; 20 Suppl 5():S23-7. PubMed ID: 11229608
[TBL] [Abstract][Full Text] [Related]
26. Development and validation of an HPLC method to quantify 3,4-dideoxyglucosone-3-ene in peritoneal dialysis fluids.
Frischmann M; Spitzer J; Fünfrocken M; Mittelmaier S; Deckert M; Fichert T; Pischetsrieder M
Biomed Chromatogr; 2009 Aug; 23(8):843-51. PubMed ID: 19353694
[TBL] [Abstract][Full Text] [Related]
27. Development of toxic degradation products during heat sterilization of glucose-containing fluids for peritoneal dialysis: influence of time and temperature.
Kjellstrand P; Martinson E; Wieslander A; Holmquist B
Perit Dial Int; 1995; 15(1):26-32. PubMed ID: 7734557
[TBL] [Abstract][Full Text] [Related]
28. Impact of 3,4-dideoxyglucosone-3-ene (3,4-DGE) on cytotoxicity of acidic heat-sterilized peritoneal dialysis fluid.
Tomo T; Okabe E; Yamamoto T; Namoto S; Iwashita T; Matsuyama K; Kadota J
J Artif Organs; 2007; 10(1):47-51. PubMed ID: 17380297
[TBL] [Abstract][Full Text] [Related]
29. Effect of glucose concentration, osmolality, and sterilization process of peritoneal dialysis fluids on cytokine production by peripheral blood mononuclear cells and polymorphonuclear cell functions in vitro.
Cendoroglo M; Sundaram S; Jaber BL; Pereira BJ
Am J Kidney Dis; 1998 Feb; 31(2):273-82. PubMed ID: 9469498
[TBL] [Abstract][Full Text] [Related]
30. Effect of two-chambered bicarbonate lactate-buffered peritoneal dialysis fluids on peripheral blood mononuclear cell and polymorphonuclear cell function in vitro.
Sundaram S; Cendoroglo M; Cooker LA; Jaber BL; Faict D; Holmes CJ; Pereira BJ
Am J Kidney Dis; 1997 Nov; 30(5):680-9. PubMed ID: 9370184
[TBL] [Abstract][Full Text] [Related]
31. Heat sterilized PD-fluids impair growth and inflammatory responses of cultured cell lines and human leukocytes.
Wieslander AP; Nordin MK; Martinson E; Kjellstrand PT; Boberg UC
Clin Nephrol; 1993 Jun; 39(6):343-8. PubMed ID: 8392917
[TBL] [Abstract][Full Text] [Related]
32. Cross-omics comparison of stress responses in mesothelial cells exposed to heat- versus filter-sterilized peritoneal dialysis fluids.
Kratochwill K; Bender TO; Lichtenauer AM; Herzog R; Tarantino S; Bialas K; Jörres A; Aufricht C
Biomed Res Int; 2015; 2015():628158. PubMed ID: 26495307
[TBL] [Abstract][Full Text] [Related]
33. Structure- and concentration-specific assessment of the physiological reactivity of α-dicarbonyl glucose degradation products in peritoneal dialysis fluids.
Distler L; Georgieva A; Kenkel I; Huppert J; Pischetsrieder M
Chem Res Toxicol; 2014 Aug; 27(8):1421-30. PubMed ID: 25033248
[TBL] [Abstract][Full Text] [Related]
34. Reducing the formation of glucose degradation products in peritoneal dialysis solutions by ultrahigh temperature ohmic heating.
Shapira A; Shazman A; Ungar Y; Shimoni E
Mol Nutr Food Res; 2007 Apr; 51(4):473-8. PubMed ID: 17390399
[TBL] [Abstract][Full Text] [Related]
35. Reduced glucose degradation products in bicarbonate/lactate-buffered peritoneal dialysis solutions produced in two-chambered bags.
Cooker LA; Luneburg P; Faict D; Choo C; Holmes CJ
Perit Dial Int; 1997; 17(4):373-8. PubMed ID: 9284465
[TBL] [Abstract][Full Text] [Related]
36. Acute inflammation in peritoneal dialysis: experimental studies in rats. Characterization of regulatory mechanisms.
Bazargani F
Swed Dent J Suppl; 2005; (171):1-57, i. PubMed ID: 15847249
[TBL] [Abstract][Full Text] [Related]
37. Degradation and de novo formation of nine major glucose degradation products during storage of peritoneal dialysis fluids.
Gensberger-Reigl S; Weigel I; Stützer J; Auditore A; Nikolaus T; Pischetsrieder M
Sci Rep; 2022 Mar; 12(1):4268. PubMed ID: 35277529
[TBL] [Abstract][Full Text] [Related]
38. Fate of the glucose degradation products 3-deoxyglucosone and glyoxal during peritoneal dialysis.
Tauer A; Bender TO; Fleischmann EH; Niwa T; Jörres A; Pischetsrieder M
Mol Nutr Food Res; 2005 Jul; 49(7):710-5. PubMed ID: 15915443
[TBL] [Abstract][Full Text] [Related]
39. Comparison of in vitro AGE formation between standard PD fluid and a novel bicarbonate/lactate formulation.
Millar DJ; Holmes C; Faict D; Dawnay A
Adv Perit Dial; 1998; 14():191-4. PubMed ID: 10649722
[TBL] [Abstract][Full Text] [Related]
40. Identification and quantification of the glucose degradation product glucosone in peritoneal dialysis fluids by HPLC/DAD/MSMS.
Mittelmaier S; Fünfrocken M; Fenn D; Fichert T; Pischetsrieder M
J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Apr; 878(11-12):877-82. PubMed ID: 20189892
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
